Phibro Animal Health Corporation (PAHC)
NASDAQ: PAHC · IEX Real-Time Price · USD
12.61
+0.17 (1.36%)
Apr 26, 2024, 10:01 AM EDT - Market open
Phibro Animal Health Market Cap
Phibro Animal Health has a market cap or net worth of $510.35 million as of April 26, 2024. Its market cap has decreased by -19.69% in one year.
Market Cap
510.35M
Enterprise Value
886.27M
1-Year Change
-19.69%
Ranking
Category
Stock Price
$12.63
Market Cap Chart
Since April 11, 2014, Phibro Animal Health's market cap has decreased from $642.80M to $510.35M, a decrease of -20.61%. That is a compound annual growth rate of -2.27%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 24, 2024 | 508.70M | -7.73% |
Apr 23, 2024 | 551.30M | 4.29% |
Apr 22, 2024 | 528.60M | -1.87% |
Apr 19, 2024 | 538.70M | 1.99% |
Apr 18, 2024 | 528.20M | 1.32% |
Apr 17, 2024 | 521.30M | -0.91% |
Apr 16, 2024 | 526.10M | -1.68% |
Apr 15, 2024 | 535.10M | 0.77% |
Apr 12, 2024 | 531.00M | 0.15% |
Apr 11, 2024 | 530.20M | -1.06% |
Apr 10, 2024 | 535.90M | 0.85% |
Apr 9, 2024 | 531.40M | 1.86% |
Apr 8, 2024 | 521.70M | 0.54% |
Apr 5, 2024 | 518.90M | -0.69% |
Apr 4, 2024 | 522.50M | -0.23% |
Apr 3, 2024 | 523.70M | 2.87% |
Apr 2, 2024 | 509.10M | -0.33% |
Apr 1, 2024 | 510.80M | -2.46% |
Mar 28, 2024 | 523.70M | -1.00% |
Mar 27, 2024 | 529.00M | 1.71% |
Mar 26, 2024 | 520.10M | 2.32% |
Mar 25, 2024 | 508.30M | 3.80% |
Mar 22, 2024 | 489.70M | -1.55% |
Mar 21, 2024 | 497.40M | -1.45% |
Mar 20, 2024 | 504.70M | 0.08% |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
ProKidney | 581.70M |
Prime Medicine | 575.71M |
Allogene Therapeutics | 569.84M |
Mineralys Therapeutics | 567.28M |
Olema Pharmaceuticals | 559.15M |
Castle Biosciences | 550.65M |
Exscientia | 550.58M |
Jin Medical International | 547.91M |